关注
Esma Bilajac
Esma Bilajac
在 student.ius.edu.ba 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
K Lundstrom, A Hromić-Jahjefendić, E Bilajac, AAA Aljabali, K Baralić, ...
Cellular Signalling 101, 110495, 2023
192023
Metformin and thymoquinone synergistically inhibit proliferation of imatinib-resistant human leukemic cells
U Glamoclija, L Mahmutovic, E Bilajac, V Soljic, K Vukojevic, M Suljagic
Frontiers in pharmacology 13, 867133, 2022
112022
COVID-19 signalome: Potential therapeutic interventions
K Lundstrom, A Hromić-Jahjefendić, E Bilajac, AAA Aljabali, K Baralić, ...
Cellular signalling 103, 110559, 2023
82023
Meet the insidious players: Review of viral infections in head and neck cancer etiology with an update on clinical trials
L Mahmutović, E Bilajac, A Hromić-Jahjefendić
Microorganisms 9 (5), 1001, 2021
82021
Curcumin decreases viability and inhibits proliferation of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cell lines
E Bilajac, L Mahmutović, U Glamočlija, A Osmanović, ...
Metabolites 13 (1), 58, 2022
62022
Viral agents as potential drivers of diffuse large B-Cell lymphoma tumorigenesis
E Bilajac, L Mahmutović, K Lundstrom, U Glamočlija, J Šutković, A Sezer, ...
Viruses 14 (10), 2105, 2022
42022
HPLC method for the determination of thymoquinone in growth cell medium
M Dedić, E Omeragić, B Imamović, E Bilajac, L Mahmutović, U Glamočlija, ...
Technology and Health Care, 1-14, 2024
2024
SYNTHESIS, IN SILICO STUDY AND ANTITUMOR ACTIVITY OF COUMARIN COMPOUNDS IN LYMPHOMA CELLS
E Bilajac, A OSMANOVIĆ, UNA GLAMOČLIJA, E VELJOVIĆ, ...
Farmacia 71 (6), 1263-1273, 2023
2023
Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells
E Bilajac, U Glamočlija, A Osmanović, L Mahmutović, A Sezer, S Roca, ...
Croatica chemica acta 96 (1), 59-68, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–9